HCA Healthcare, Inc. (NYSE:HCA) Shares Sold by O Shaughnessy Asset Management LLC

O Shaughnessy Asset Management LLC lessened its stake in HCA Healthcare, Inc. (NYSE:HCA) by 12.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 42,647 shares of the company’s stock after selling 6,325 shares during the period. O Shaughnessy Asset Management LLC’s holdings in HCA Healthcare were worth $12,800,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also made changes to their positions in HCA. Legacy Investment Solutions LLC purchased a new stake in HCA Healthcare in the third quarter valued at approximately $39,000. Whipplewood Advisors LLC purchased a new position in HCA Healthcare during the 4th quarter worth $31,000. Tidemark LLC purchased a new stake in shares of HCA Healthcare in the fourth quarter valued at about $36,000. Activest Wealth Management grew its holdings in shares of HCA Healthcare by 1,250.0% during the fourth quarter. Activest Wealth Management now owns 135 shares of the company’s stock worth $40,000 after buying an additional 125 shares during the last quarter. Finally, Pinnacle Bancorp Inc. raised its stake in HCA Healthcare by 50.0% during the 4th quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company’s stock valued at $45,000 after acquiring an additional 50 shares during the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

HCA has been the subject of several analyst reports. KeyCorp cut their price target on HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating for the company in a research note on Tuesday, January 7th. Bank of America lowered their target price on shares of HCA Healthcare from $380.00 to $370.00 and set a “buy” rating on the stock in a report on Monday, January 27th. Barclays reduced their price objective on shares of HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating for the company in a research report on Monday, January 27th. Morgan Stanley reduced their price target on HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating for the company in a report on Tuesday, December 17th. Finally, Truist Financial cut their price objective on HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a research report on Monday, January 6th. One analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have issued a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $385.67.

HCA Healthcare Price Performance

Shares of NYSE:HCA opened at $346.08 on Tuesday. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.97 and a current ratio of 1.08. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $417.14. The business’s fifty day moving average price is $325.24 and its two-hundred day moving average price is $340.60. The stock has a market cap of $85.20 billion, a PE ratio of 15.75, a price-to-earnings-growth ratio of 1.10 and a beta of 1.68.

HCA Healthcare (NYSE:HCA) last released its earnings results on Friday, January 24th. The company reported $6.22 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same period last year, the business posted $5.90 EPS. On average, analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, March 31st. Investors of record on Monday, March 17th were given a dividend of $0.72 per share. The ex-dividend date was Monday, March 17th. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.66. This represents a $2.88 annualized dividend and a yield of 0.83%. HCA Healthcare’s dividend payout ratio is 13.11%.

Insider Buying and Selling at HCA Healthcare

In related news, SVP Jennifer Berres sold 9,533 shares of the business’s stock in a transaction that occurred on Friday, February 14th. The shares were sold at an average price of $322.59, for a total value of $3,075,250.47. Following the completion of the sale, the senior vice president now directly owns 15,412 shares in the company, valued at approximately $4,971,757.08. The trade was a 38.22 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.30% of the stock is owned by company insiders.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.